{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:06:05Z","timestamp":1788930365611,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.drugalcdep.2014.10.014","type":"journal-article","created":{"date-parts":[[2014,10,24]],"date-time":"2014-10-24T21:41:37Z","timestamp":1414186897000},"page":"185-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Ethnic and genetic factors in methadone pharmacokinetics: A population pharmacokinetic study"],"prefix":"10.1016","volume":"145","author":[{"given":"Gavin","family":"Bart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Straka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Brundage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jsat.2011.12.006","article-title":"Superior methadone treatment outcome in Hmong compared with non-Hmong patients","volume":"43","author":"Bart","year":"2012","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mcp.2001.116793","article-title":"Pharmacokinetics and pharmacodynamics of methadone enantiomers after a single oral dose of racemate","volume":"70","author":"Boulton","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0015","series-title":"Methadone Mortality\u2014A Reassessment","author":"Center for Substance Abuse Treatment","year":"2007"},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1742-7843.2010.00628.x","article-title":"Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation","volume":"108","author":"Chang","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0025","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.clpt.2006.09.011","article-title":"ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals","volume":"80","author":"Coller","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0030","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.clpt.2006.09.012","article-title":"ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment","volume":"80","author":"Crettol","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0035","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.clpt.2005.08.011","article-title":"Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment","volume":"78","author":"Crettol","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugalcdep.2009.05.021","article-title":"Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved","volume":"105","author":"Degenhardt","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0045","first-page":"13","article-title":"SCL-90: an outpatient psychiatric rating scale\u2014preliminary report","volume":"9","author":"Derogatis","year":"1973","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0050","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence","volume":"41","author":"Eap","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0055","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders\u2014Patient Edition (SCID-I\/P, Version 2.0, 8\/98 Revision","author":"First","year":"1998"},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0060","series-title":"Guidance for Industry: Population Pharmacokinetics","author":"Food and Drug Administration","year":"1999"},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0065","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2125.2004.02079.x","article-title":"Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients","volume":"57","author":"Foster","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/chir.10303","article-title":"Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19","volume":"16","author":"Gerber","year":"2004","journal-title":"Chirality"},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1742-6405-7-32","article-title":"Presence of the CYP2B6 516G>T polymorphism, increased plasma Efavirenz concentrations and early neuropsychiatric side effects in South African HIV-infected patients","volume":"7","author":"Gounden","year":"2010","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0080","first-page":"2391","article-title":"Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study","volume":"18","author":"Haas","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0085","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1124\/jpet.107.133306","article-title":"Aberrant splicing caused by single nucleotide polymorphism c.516G>T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liver","volume":"325","author":"Hofmann","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0090","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2217\/pgs.11.96","article-title":"Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients","volume":"12","author":"Hung","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0095","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2125.2003.02053.x","article-title":"The effect of quinidine, used as a probe for the involvement of P-glycoprotein, on the intestinal absorption and pharmacodynamics of methadone","volume":"57","author":"Kharasch","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0100","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/ALN.0b013e3181986a9a","article-title":"Methadone pharmacokinetics are independent of cytochrome P4503A (CYP3A) activity and gastrointestinal drug transport: insights from methadone interactions with ritonavir\/indinavir","volume":"110","author":"Kharasch","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0105","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2008.12.009","article-title":"Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity","volume":"101","author":"Kharasch","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0110","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/clpt.2011.276","article-title":"Mechanism of efavirenz influence on methadone pharmacokinetics and pharmacodynamics","volume":"91","author":"Kharasch","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0115","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1001\/jama.2008.648","article-title":"Methadone maintenance 4 decades later: thousands of lives saved but still controversial","volume":"300","author":"Kleber","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/1097-0258(20010115)20:1<75::AID-SIM602>3.0.CO;2-C","article-title":"Design evaluation for a population pharmacokinetic study using clinical trial simulations: a case study","volume":"20","author":"Kowalski","year":"2001","journal-title":"Stat. Med."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0125","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00008571-200107000-00004","article-title":"Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver","volume":"11","author":"Lang","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0130","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/FPC.0b013e32834a522e","article-title":"Integration of absorption, distribution, metabolism, and elimination genotyping data into a population pharmacokinetic analysis of nevirapine","volume":"21","author":"Lehr","year":"2011","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0135","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/ddn122","article-title":"ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence","volume":"17","author":"Levran","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jchromb.2004.03.059","article-title":"Method development and validation for quantitative determination of methadone enantiomers in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"806","author":"Liang","year":"2004","journal-title":"J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0145","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ajpa.21408","article-title":"Southeast Asian origins of five Hill Tribe populations and correlation of genetic to linguistic relationships inferred with genome-wide SNP data","volume":"144","author":"Listman","year":"2011","journal-title":"Am. J. Phys. Anthropol."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2156-8-21","article-title":"Demographic changes and marker properties affect detection of human population differentiation","volume":"8","author":"Listman","year":"2007","journal-title":"BMC Genet."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1365-2125.1999.00974.x","article-title":"Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes","volume":"48","author":"Rostami-Hodjegan","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev.pa.32.040192.001153","article-title":"Population pharmacokinetics\/dynamics","volume":"32","author":"Sheiner","year":"1992","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0165","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF01061728","article-title":"Estimation of population characteristics of pharmacokinetic parameters from routine clinical data","volume":"5","author":"Sheiner","year":"1977","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0170","doi-asserted-by":"crossref","first-page":"c4851","DOI":"10.1136\/bmj.c4851","article-title":"Impact of supervision of methadone consumption on deaths related to methadone overdose (1993\u20132008): analyses using OD4 index in England and Scotland","volume":"341","author":"Strang","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0175","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/00000542-200005000-00030","article-title":"Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein","volume":"92","author":"Thompson","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0180","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/jpet.106.117580","article-title":"Enantiomeric metabolic interactions and stereoselective human methadone metabolism","volume":"321","author":"Totah","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0185","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ALN.0b013e3181642938","article-title":"Role of CYP2B6 in stereoselective human methadone metabolism","volume":"108","author":"Totah","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0190","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00213-003-1718-1","article-title":"Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice","volume":"173","author":"Wang","year":"2004","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0195","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF00315479","article-title":"Steady-state pharmacokinetics of methadone in opioid addicts","volume":"44","author":"Wolff","year":"1993","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0200","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2125.1997.t01-1-00591.x","article-title":"The pharmacokinetics of methadone in healthy subjects and opiate users","volume":"44","author":"Wolff","year":"1997","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2014.10.014_bib0205","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00439-005-0012-1","article-title":"Examination of ancestry and ethnic affiliation using highly informative diallelic DNA markers: application to diverse and admixed populations and implications for clinical epidemiology and forensic medicine","volume":"118","author":"Yang","year":"2005","journal-title":"Hum. Genet."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614018778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614018778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T03:30:06Z","timestamp":1538105406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871614018778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":41,"alternative-id":["S0376871614018778"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.10.014","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethnic and genetic factors in methadone pharmacokinetics: A population pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}